Sales
The objective of the FINA BIOTECH Sales Division is to out license the results of the research projects funded by the company, thereby making the advances of our researchers available to the largest possible number of patients.
To this end, our work consists of LOCATING, CONTACTING and NEGOTIATING with pharmaceutical or biotechnology companies specialized in the areas of each one of our products, whether completed or still in development.
In September 2007 we have made an agreement with the Spanish company HALOTECH DNA, by which this company produce and sell exclusively, on a worldwide basis, the kit HALOSPERM TM. The customers and companies interested in the distribution and/or information of the product should contact HALOTECH DNA.
Another finished project that has attracted the interest of the pharmaceutical industry is F-12 TM, a diagnostic kit for detecting the predisposition of certain groups of patients to deep-vein thrombosis (DVT) as a result of a genetic mutation that affects the clotting process.
Our diagnostic products in oncology and cardiovascular, as well as the regenerative therapy with adult stem cells are being seen with interest by a large number of companies of the diagnosis, pharmaceutical and biotech field..
FINA BIOTECH's Sales Division also collaborates on the commercial viability studies performed for all projects submitted to our company to assess their market potential and growth prospects.
Sales Manager